Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-28

Clinical Trial Update: Evaluation of Naloxegol in the Prevention of POI After Cystectomy [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating naloxegol for preventing postoperative ileus after cystectomy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxegol (naloxegol)

Snippet

Sponsor: Institut Paoli-Calmettes | Conditions: Bladder Cancer, Cystostomy; Complications | Phase 2 | Status: UNKNOWN